Branislav Bystrický
Impact in
-
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 11
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Lung Cancer Treatments and Mutations 2
- Sarcoma Diagnosis and Treatment 1
- Vasculitis and related conditions 1
- Co-authors
- Michal Mego (7 shared papers)Ľuboš Drgoňa (3 shared papers)Daniela Světlovská (3 shared papers)Jozef Chovanec (3 shared papers)Mária Rečková (3 shared papers)Jozef Mardiak (3 shared papers)Ian Chau (2 shared papers)Stanislav Spanik (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Anticancer Research (2 papers)Drugs (1 paper)Complementary Therapies in Medicine (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- SlovakiaUnited KingdomPoland
In The Last Decade
Branislav Bystrický
27 papers receiving 628 citations
Peers
Comparison fields: 5 of 90
- Oncology 238
- Cancer Research 52
- Pulmonary and Respiratory Medicine 104
- Molecular Biology 198
- Health Informatics 4
Countries citing papers authored by Branislav Bystrický
This map shows the geographic impact of Branislav Bystrický's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branislav Bystrický with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branislav Bystrický more than expected).
Fields of papers citing papers by Branislav Bystrický
This network shows the impact of papers produced by Branislav Bystrický. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branislav Bystrický. The network helps show where Branislav Bystrický may publish in the future.
Co-authors
The 25 scholars most cited alongside Branislav Bystrický, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 231 | |
| 2 | 2015 | 199 | |
| 3 | 2017 | 44 | |
| 4 | 2010 | 25 | |
| 5 | 2010 | 16 | |
| 6 | 2017 | 16 | |
| 7 | 2023 | 16 | |
| 8 | 2011 | 15 | |
| 9 | 2015 | 12 | |
| 10 | 2017 | 10 | |
| 11 | 2016 | 8 | |
| 12 | 2016 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2017 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2016 | 4 | |
| 19 | 2012 | 4 | |
| 20 | 2024 | 2 |
About Branislav Bystrický
Branislav Bystrický is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Neurology, having authored 27 papers that have together received 646 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (2 papers), Multiple and Secondary Primary Cancers (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Ovarian cancer diagnosis and treatment (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Oncology (238 citations), Cancer Research (52 citations), Pulmonary and Respiratory Medicine (104 citations), Molecular Biology (198 citations) and Health Informatics (4 citations). Branislav Bystrický has collaborated with scholars based in Slovakia, United Kingdom and Poland. Frequent co-authors include Michal Mego, Ľuboš Drgoňa, Daniela Světlovská, Jozef Chovanec, Mária Rečková, Jozef Mardiak, Ian Chau, Stanislav Spanik, Vladimír Zajac and Věra Miškovská. Their work appears in journals such as Frontiers in Oncology, Anticancer Research, Drugs, Complementary Therapies in Medicine and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.